Doughertys Pharmacy (ASDS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ASDS Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Doughertys Pharmacy's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2019)
(Dec 31 2018) (Sep 30 2018) (Jun 30 2018) (Mar 31 2018)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Accounts receivable1.42
Other Receivables, Net, Current0.31
Inventories2.73
Other Current Assets0.00
Prepaid Expense, Current AS0.21
Total Current Assets4.74
Equipment/Property/Plant Net0.84
Intangible Assets2.05
Long-term investments0.45
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent0.00
Other Assets, Noncurrent4.53
Total Assets12.61
Liabilities
Accounts Payable, Current AC3.11
Accrued Liabilities, Current AC0.44
Notes Payable, Current NO0.82
Other Liabilities, Current4.40
Total Current Liabilities8.76
Long-term debt2.10
Total Long-term Debt2.10
Other liabilities, Noncurrent4.15
Total Liabilities15.01
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.40
Additional Paid In Capital Common Stock60.22
Retained Earnings / Accumulated Deficit-62.22
Other Equity0.00
Common Stockholder's Equity-2.40
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-2.40
Liabilities & Stockholder's Equity12.61
4 historic quarters locked

Sign in to unlock the full Doughertys Pharmacy balance sheet history.

About ASDS Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.